Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Masters

Showing results (271-280 of 278) with videos related to

Pageof 28
Sort By:
You have reached the last page of results.This site can display upto 278 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2021
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trialA Bardia, W A Messersmith, E A Kio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Therapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I-inhibiting Antibody-Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab GovitecanJhanelle E Gray, Rebecca S Heist, Alexander N Starodub, et al.
Journal for Immunotherapy of Cancer|June 26, 2021
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse eventsJulie R Brahmer, Hamzah Abu-Sbeih, Paolo Antonio Ascierto, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|December 16, 2023
The 2023 Orthopaedic Research Society's International Consensus Meeting on musculoskeletal infection: Summary from the host immunity sectionEdward M Schwarz, Nathan K Archer, Gerald J Atkins, et al.
Bone Research|October 25, 2019
Evolving concepts in bone infection: redefining "biofilm", "acute vs. chronic osteomyelitis", "the immune proteome" and "local antibiotic therapy"Elysia A Masters, Ryan P Trombetta, Karen L de Mesy Bentley, et al.
Nature Nanotechnology|July 19, 2022
Nanomedicine platform for targeting activated neutrophils and neutrophil-platelet complexes using an α<sub>1</sub>-antitrypsin-derived peptide motifMichelle A Cruz, Dillon Bohinc, Elizabeth A Andraska, et al.
Cancer Research Communications|July 27, 2023
Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 BenefitBenjamin J Bulen, Nickolay A Khazanov, Daniel H Hovelson, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|June 29, 2023
Abstracts of presentations to the Annual Meetings of the Canadian Society of Colon and Rectal Surgeons Canadian Association of General Surgeons Canadian Association of Thoracic Surgeons: Canadian Surgery Forum, London, Ont., Sept. 19 to 22, 2002T K Asano, R S McLeod, M Blitz, et al.
Pageof 28

Showing results (271-280 of 278) with videos related to

Sort By:
Pageof 28
You have reached the last page of results.This site can display upto 278 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2021
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trialA Bardia, W A Messersmith, E A Kio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Therapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I-inhibiting Antibody-Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab GovitecanJhanelle E Gray, Rebecca S Heist, Alexander N Starodub, et al.
Journal for Immunotherapy of Cancer|June 26, 2021
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse eventsJulie R Brahmer, Hamzah Abu-Sbeih, Paolo Antonio Ascierto, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|December 16, 2023
The 2023 Orthopaedic Research Society's International Consensus Meeting on musculoskeletal infection: Summary from the host immunity sectionEdward M Schwarz, Nathan K Archer, Gerald J Atkins, et al.
Bone Research|October 25, 2019
Evolving concepts in bone infection: redefining "biofilm", "acute vs. chronic osteomyelitis", "the immune proteome" and "local antibiotic therapy"Elysia A Masters, Ryan P Trombetta, Karen L de Mesy Bentley, et al.
Nature Nanotechnology|July 19, 2022
Nanomedicine platform for targeting activated neutrophils and neutrophil-platelet complexes using an α<sub>1</sub>-antitrypsin-derived peptide motifMichelle A Cruz, Dillon Bohinc, Elizabeth A Andraska, et al.
Cancer Research Communications|July 27, 2023
Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 BenefitBenjamin J Bulen, Nickolay A Khazanov, Daniel H Hovelson, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|June 29, 2023
Abstracts of presentations to the Annual Meetings of the Canadian Society of Colon and Rectal Surgeons Canadian Association of General Surgeons Canadian Association of Thoracic Surgeons: Canadian Surgery Forum, London, Ont., Sept. 19 to 22, 2002T K Asano, R S McLeod, M Blitz, et al.
Pageof 28